Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prehospital pain treatment with Actiq in acute STEMI
2005-005922-29Phase 4Terminated
- Sponsor
- Anæstesisektor Nordjylland
- Start
- Jul 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of fentanyl in acute ST-segment elevation myocardial infarction (STEMI), sponsored by Anæstesisektor Nordjylland. Primary endpoints: Pain reduction to VAS less than or equal to 3, Mortality at 3 months after PCI and 2 more. Started Jul 2006; status: terminated.
02
Drugs
fentanyl
03
Conditions
acute ST-segment elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on 2005-005922-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005922-29.